N
NRC Research Institute | Los Angeles, CA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
KarXT
Olezarsen
Semaglutide
LB-102
ENX-102
Parent organization
This site is a part of NRC Research Institute
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 5 total trials
The purpose of this study is to evaluate the efficacy and safety of KarXT for the treatment of manic episodes in Bipolar-I Disorder
Enrolling
Bipolar-I Disorder With Mania or Mania With Mixed Features
Drug: KarXT
Other: Placebo
Phase II study for patients with Bipolar 1 Disorder experiencing major depressive episode. Patient eligible for enrollment will be randomized (like f...
Enrolling
Bipolar I Disorder
Other: Placebo
Drug: LB-102
Trial sponsors
E
L
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems